Humphrey CD, Lawrence AC
Patients should inform their procedural and anesthesia teams if they take GLP-1 or dual incretin therapy, including Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda, Mounjaro, or Zepbound
You may be a candidate if you have: BMI 27 kg/m with obesity-related health problems BMI 30 kg/m Type 2 diabetes with overweight Fatty liver disease PCOS with obesity Sleep apnea High blood pressure Difficulty losing weight despite lifestyle changes A complete medical evaluation is essential before starting treatment
Dosing & Titration Guide Reconstituted with the supplied 3 ml bacteriostatic water, this 20 mg vial yields 6.67 mg/mL
Moreover, a large number of clinical trials and early regulatory approvals accelerate the introduction of new formulations
A patient sat across from me last year six weeks into semaglutide, finally feeling her appetite shift for the first time in years and asked me something I hear in almost every follow-up: "Do I still have to watch what I eat, or does the medication handle that now?" It's a fair question
